Funding for this research was provided by:
Text and Data Mining valid from 2018-05-31
Received: 21 November 2017
Accepted: 20 April 2018
First Online: 31 May 2018
Ethics approval and consent to participate
: This study was approved by RTI International’s Office of Research Protection (ID 13967). All respondents provided informed consent at the time of completing the survey.
: MEH is a consultant to AbbVie and Janssen, and has served on advisory boards for AbbVie, Celgene, Genentech, Bristol-Myers Squibb, Lilly, Pfizer, Novartis, and Janssen. AF is a speaker as well as a consultant to AbbVie, and has served as a researcher for Mallinkrodt, Roche, and AbbVie. BH and JS are full-time employees of RTI Health Solutions, which has received consulting fees from AbbVie to partner on this research. JP was a full-time employee of RTI Health Solutions when this research was conducted. RS and AG are full-time AbbVie employees and own AbbVie stock.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.